Biopharmaceutical News and Research

RSS

IONTAS founder and pioneer in phage display technology attends Nobel Prize Award Ceremony

Dr. John McCafferty celebrates the success of phage display technology with Nobel Prize in Chemistry Laureates.

From FairJourney Biologics 12 Dec 2018

New therapeutic strategy is emerging for type 2 diabetes

Diabetes is a disease in which blood sugar levels are high over a prolonged period (hyperglycemia). In the case of type 2 diabetes, this phenomenon which is caused by a disruption of the glucose metabolism develops progressively and insidiously.

6 Dec 2018

Governments across Europe respond in very different ways to lung cancer

The World Health Organization estimates 387,913 Europeans will die of lung cancer in 2018. The preliminary findings from a new study by the Economist Intelligence Unit comparing 13 countries show that governments across Europe are responding in very different ways to the disease.

4 Dec 2018

Scientist.com and Allele Biotechnology partner to develop therapeutic nanoantibodies

Scientist.com, the world's leading marketplace for outsourced scientific services, and Allele Biotechnology & Pharmaceuticals Inc., a leading San Diego-based preclinical-stage biopharmaceutical company, have partnered to develop nanoantibodies for therapeutic applications.

3 Dec 2018

SSB enters into collaboration with Immunochina to develop new immunotherapy equipment

Sartorius Stedim Biotech, a leading international supplier of the biopharmaceutical industry, through its China affiliate, and Beijing-based Immunochina Pharmaceuticals, announced today that both parties have entered into a collaboration.

3 Dec 2018

Aurora Biomed organizes 2018 Shunde Biomedical Industry Investment Promotion Conference

From November 14-17, the "2018 Shunde Biomedical Industry Investment Promotion Conference" which ran in parallel with the Precision Medicine and Ion Channel Retreat was successfully held at the Ramada Plaza Hotel, Shunde, Guang Dong, China.

3 Dec 2018

Insights from the Shunde Biomedical Industry Investment Promotion Conference

From November 14-17, the 2018 Shunde Biomedical Industry Investment Promotion Conference was successfully held at the Ramada Plaza Hotel, Shunde, GuangDong, China

From Aurora Biomed Inc. 29 Nov 2018

Using Pre-Clinical Imaging to Detect Cancer

In this interview, Émilie Beaulieu Ouellet, Application Scientist for life science imaging at Photon Etc talks to New-Medical about their range of preclinical infrared imagers and how they can allow cancer detection.

From Photon etc. 27 Nov 2018

Report shows strong but uneven spending in medical and health R&D over five-year period in the U.S.

Total U.S. investment in medical and health research and development in the U.S. grew by 27% over the five-year period from 2013 to 2017, led by industry and the federal government, according to U.S. Investments in Medical and Health Research and Development, a new report from Research!America.

21 Nov 2018

Breakthrough technology offers new hope to people with glaucoma, retinitis and macular degeneration

In January 2009, the life of engineer Michel Meunier, a professor at Polytechnique Montréal, changed dramatically. Like others, he had observed that the extremely short pulse of a femtosecond laser (0.000000000000001 second) could make nanometer-sized holes appear in silicon when it was covered by gold nanoparticles.

20 Nov 2018

Automating Data Capture and Image Analysis in Continuous Experiments

An interview with Lindy O’Clair, discussing the challenges of studying neuronal systems over time, and the development of an automated platform by Sartorius.

From Sartorius 19 Nov 2018

EMA recommends first all-oral treatment to tackle deadly sleeping sickness

The European Medicines Agency's Committee for Medicinal Products for Human Use has adopted a positive scientific opinion of fexinidazole, the first all-oral treatment that has been shown to be efficacious for both stages of sleeping sickness.

16 Nov 2018

FDA approves LORBRENA for treatment of patients with ALK-positive metastatic NSCLC

Pfizer Inc. today announced that the U.S. Food and Drug Administration has approved LORBRENA, a third-generation anaplastic lymphoma kinase tyrosine kinase inhibitor for patients with ALK-positive metastatic non-small cell lung cancer whose disease has progressed on crizotinib and at least one other ALK inhibitor for metastatic disease; or whose disease has progressed on alectinib or ceritinib as the first ALK inhibitor therapy for metastatic disease.

5 Nov 2018

AstraZeneca to present Phase III CVOT DECLARE-TIMI 58 results at AHA Scientific Sessions

AstraZeneca will present 20 abstracts including a late-breaking oral presentation on the full results from the Phase III cardiovascular outcomes trial DECLARE -TIMI 58, the broadest SGLT2 inhibitor CVOT conducted to date, as well as new research from the Company's Cardiovascular, Renal & Metabolism therapy area at the American Heart Association Scientific Sessions, November 10-12, 2018, in Chicago, Illinois, USA.

1 Nov 2018

PAREXEL launches new China Advisory Service to help global biopharmaceutical companies navigate market opportunity within China

PAREXEL International Corporation has announced a new China Advisory Service to help global biopharmaceutical companies participate in the growing, yet complex market opportunity within China.

From Parexel 1 Nov 2018

Insilico to present its research in AI for drug discovery at BioCentury China HealthCare Summit

Insilico Medicine, a Rockville-based company developing the end-to-end drug discovery pipeline utilizing the next generation artificial intelligence, will present its research in AI for drug discovery at BioCentury China HealthCare Summit in Shanghai, 13-14 of November.

31 Oct 2018

Cellix Bio announces completion of Pre-IND meeting with FDA on novel prodrug of mesalamine for ulcerative colitis

Cellix Biosciences Inc., a development-stage pharmaceutical company, today announced successful completion of a Pre-Investigational New Drug meeting with the U.S. Food and Drug Administration for the development of CLX-103, a novel molecular conjugate of mesalamine for the treatment of mild to moderate ulcerative colitis.

30 Oct 2018

Study examines effects of walking exercise training on cognitive function in people with MS

John DeLuca, PhD, senior vice president for Research and Training at Kessler Foundation, has received a $95,000 sub-award from EMD Serono, the biopharmaceutical business of Merck KGaA, Darmstadt, Germany, in the U.S. and Canada.

29 Oct 2018

AbbVie’s U-ACHIEVE Phase 2b/3 dose-ranging study improves outcomes in patients with ulcerative colitis

AbbVie, a research-based global biopharmaceutical company, today announced positive results from U-ACHIEVE, an ongoing Phase 2b/3 dose-ranging study evaluating upadacitinib, an investigational JAK1-selective inhibitor, for induction and maintenance therapy in adult patients with moderately to severely active ulcerative colitis.

23 Oct 2018

FOTIVDA expected to be included in new ESMO guidelines for advanced renal cell carcinoma

EUSA Pharma welcomes the news that FOTIVDA (tivozanib) is expected to be included in the upcoming European Society of Medical Oncology clinical practice guidelines for advanced renal cell carcinoma, anticipated to be published at the end of this year.

22 Oct 2018

Biopharmaceutical News and Research

IONTAS founder and pioneer in phage display technology attends Nobel Prize Award Ceremony

New therapeutic strategy is emerging for type 2 diabetes

Governments across Europe respond in very different ways to lung cancer

Scientist.com and Allele Biotechnology partner to develop therapeutic nanoantibodies

SSB enters into collaboration with Immunochina to develop new immunotherapy equipment

Aurora Biomed organizes 2018 Shunde Biomedical Industry Investment Promotion Conference

Insights from the Shunde Biomedical Industry Investment Promotion Conference

Using Pre-Clinical Imaging to Detect Cancer

Report shows strong but uneven spending in medical and health R&D over five-year period in the U.S.

Breakthrough technology offers new hope to people with glaucoma, retinitis and macular degeneration

Automating Data Capture and Image Analysis in Continuous Experiments

EMA recommends first all-oral treatment to tackle deadly sleeping sickness

FDA approves LORBRENA for treatment of patients with ALK-positive metastatic NSCLC

AstraZeneca to present Phase III CVOT DECLARE-TIMI 58 results at AHA Scientific Sessions

PAREXEL launches new China Advisory Service to help global biopharmaceutical companies navigate market opportunity within China

Insilico to present its research in AI for drug discovery at BioCentury China HealthCare Summit

Cellix Bio announces completion of Pre-IND meeting with FDA on novel prodrug of mesalamine for ulcerative colitis

Study examines effects of walking exercise training on cognitive function in people with MS

AbbVie’s U-ACHIEVE Phase 2b/3 dose-ranging study improves outcomes in patients with ulcerative colitis

FOTIVDA expected to be included in new ESMO guidelines for advanced renal cell carcinoma

Event guide: World ADC San Diego eBook

Advancing Neuroscience Research Through Collaboration and Patient-Centered Innovation

The impact of vibration on microscopy

How Omics Technologies Are Transforming Biological Research and Drug Discovery

Latest News